Michael Sang Hughes

6PUBLICATIONS
12CO-AUTHORS
AutoimmunitySolid tumoursMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis.

|Jul 17, 2025
Long-term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101.

Michael Sang Hughes, Samuel Pan, Rajshekhar Chakraborty

|Feb 24, 2025
Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma Therapies.

Michael Sang Hughes, Metodi Balev, Jai Radhakrishnan

|Feb 05, 2025
Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody.

Divaya Bhutani, Rajshekhar Chakraborty, Karan Wats

|Aug 02, 2022
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.

Michael S Hughes, Cole H Sterling, Ravi Varadhan

|Jul 10, 2019
Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control.

Michael S Hughes, Hui Zheng, Leyre Zubiri

Pageof 1

Frequent Collaborators

2 joint publications

Divaya Bhutani

1 joint publications

Gabriel E Molina

1 joint publications

Meghan J Mooradian

1 joint publications

Tania Jain